Skip to main content
OCUL logo
OCUL
(NASDAQ)
Ocular Therapeutix, Inc.
$8.62-- (--)
Loading... - Market loading

Ocular Therapeutix (OCUL) Stock Price & Financial Analysis

Ocular Therapeutix Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.32 - $8.68
52-Week High$16.44
52-Week Low$6.23
Open$8.50
Volume1.81M
Average Volume (3M)2.84M
Market Cap1.93B
Shares Outstanding224.10M
Price to Sales (P/S)37.12
Price to Book (P/B)3.32
EV/EBITDA-4.90
Revenue (TTM)52.04M
Net Income (TTM)-290.50M
Free Cash Flow (TTM)-240.94M
EPS (TTM)$-1.45
Profit Margin-558.24%
Operating Margin-575.42%
Return on Equity (ROE)-49.95%
Debt to Equity0.14
50-Day MA$9.15
200-Day MA$10.20
52-Week Change-27.93%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Ocular Therapeutix

What is the current stock price for OCUL?

As of the latest trading session, OCUL stock trades at $8.62. The 52-week range is $6.23–$16.44, with a day range of $8.32–$8.68.

What is the P/E ratio for OCUL?

The P/E ratio (Price-to-Earnings) for OCUL is shown in the Key Statistics section. This valuation metric helps compare Ocular Therapeutix, Inc. to industry peers.

Does OCUL pay dividends?

Ocular Therapeutix does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OCUL?

Based on 11 analysts, the consensus for OCUL is Buy.

What is the market cap of OCUL?

Ocular Therapeutix's market capitalization is $1.93B, classifying it as a small-cap company. Ocular Therapeutix operates in the Healthcare sector within the Biotechnology industry.